<p><i>NA</i> = Not acceptable samples</p><p><i>A</i> = Acceptable samples</p><p>Cosmic DB = Cosmic database of somatic mutations</p><p>Frequency distribution of single point mutations occurring at codon 12 of K-RAS in morphologically not acceptable, acceptable and dataset mCRC-derived tumor specimens.</p
<p>Distribution of the number of mutations according to mutational signatures in HR+/HER2− metastati...
These cases were selected because they are representative of most tumors in our database.<p><b>Copyr...
<p>Gender, age, and tumor location distribution of cases used in <i>KRAS</i> and <i>BRAF</i> mutatio...
<p>The frequencies of each specific mutation at codon 12 of K-RAS in not acceptable (<i>NA</i>) or a...
<p>Acceptable (<i>A</i>) and not acceptable (<i>NA</i>) tumor specimens with mutated (MUT) or wild-t...
<p><i>NA</i> = Not acceptable samples</p><p><i>A</i> = Acceptable samples</p><p>NSCL SM-EGFR DB = Da...
The occurrence of specific mutations in (A) all tissues, (B) the pancreas, (C) the large intestine, ...
A. Distribution by type of mutation. The COSMIC mutations were partitioned into non-coding (5’ UTR, ...
<p>A. <i>PIK3CA</i> mutations. B. <i>KRAS</i> mutations. C. <i>NRAS</i> mutations. D. <i>BRAF</i> mu...
<p>Boxplots show the CNA frequency distributions among tumor samples in 10 randomly selected cancer ...
<p>Percentage of tumors with mutations in <i>KRAS</i>, <i>BRAF</i> or <i>NRAS</i> as reported in the...
a. The graphical summary of somatic mutations of the 4 genes in molecular subtypes. All of the 190 t...
(A) Cumulative distribution of codon mutability of silent (green), nonsense (red) and missense (blue...
Statistical analysis of pathogenicity of somatic mutations in cancer Recent large-scale sequencing s...
<p>Prevalence of oncogenic mutations detected by MUT-MAP in (A) breast and (B) colorectal tumors com...
<p>Distribution of the number of mutations according to mutational signatures in HR+/HER2− metastati...
These cases were selected because they are representative of most tumors in our database.<p><b>Copyr...
<p>Gender, age, and tumor location distribution of cases used in <i>KRAS</i> and <i>BRAF</i> mutatio...
<p>The frequencies of each specific mutation at codon 12 of K-RAS in not acceptable (<i>NA</i>) or a...
<p>Acceptable (<i>A</i>) and not acceptable (<i>NA</i>) tumor specimens with mutated (MUT) or wild-t...
<p><i>NA</i> = Not acceptable samples</p><p><i>A</i> = Acceptable samples</p><p>NSCL SM-EGFR DB = Da...
The occurrence of specific mutations in (A) all tissues, (B) the pancreas, (C) the large intestine, ...
A. Distribution by type of mutation. The COSMIC mutations were partitioned into non-coding (5’ UTR, ...
<p>A. <i>PIK3CA</i> mutations. B. <i>KRAS</i> mutations. C. <i>NRAS</i> mutations. D. <i>BRAF</i> mu...
<p>Boxplots show the CNA frequency distributions among tumor samples in 10 randomly selected cancer ...
<p>Percentage of tumors with mutations in <i>KRAS</i>, <i>BRAF</i> or <i>NRAS</i> as reported in the...
a. The graphical summary of somatic mutations of the 4 genes in molecular subtypes. All of the 190 t...
(A) Cumulative distribution of codon mutability of silent (green), nonsense (red) and missense (blue...
Statistical analysis of pathogenicity of somatic mutations in cancer Recent large-scale sequencing s...
<p>Prevalence of oncogenic mutations detected by MUT-MAP in (A) breast and (B) colorectal tumors com...
<p>Distribution of the number of mutations according to mutational signatures in HR+/HER2− metastati...
These cases were selected because they are representative of most tumors in our database.<p><b>Copyr...
<p>Gender, age, and tumor location distribution of cases used in <i>KRAS</i> and <i>BRAF</i> mutatio...